MIRA INFORM
REPORT
|
Report Date : |
11.03.2011 |
IDENTIFICATION DETAILS
|
Name : |
ZENUFA LABORATORIES LIMITED |
|
|
|
|
Registered Office : |
Plot
No. 3/4, |
|
|
|
|
Country : |
|
|
|
|
|
Date of Incorporation : |
25.02.2005 |
|
|
|
|
Com. Reg. No.: |
30621 |
|
|
|
|
Legal Form : |
Limited Corporation |
|
|
|
|
Line of Business : |
wholesaling and retailing of pharmaceutical products |
RATING & COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Maximum Credit Limit : |
USD 100,000 |
|
Status : |
Moderate |
|
Payment
Behaviour : |
No Complaints |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – December 31, 2010
|
Country Name |
Previous Rating (30.09.2010) |
Current Rating (31.12.2010) |
|
|
b1 |
b1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
SUBJECT'S NAME
Registered Name: ZENUFA LABORATORIES LIMITED
Requested Name: ZENUFA
LABORATORIES LIMITED
Other Names: None found.
ADDRESS AND TELECOMMUNICATION
Physical Address: Plot No.
3/4,
Postal Address:
Country:
Phone: 255-22-2184620/2553/2
Fax: 255-22-2182551
Email: karasal@zenufa.com
Website: www.zenufa.com
CREDIT OPINION
Financial Index as of December 2010 shows subject firm with a medium risk
of credit. We recommend Credit of USD 100,000 on 90 days.
LEGAL
Legal Form: Limited Corporation
Date Incorporated: 25-Feb-2005
Reg. Number: 30621
Nominal Capital TZS. 10,000,000
Subscribed Capital TZS. 10,000,000
Subscribed Capital is Subscribed in the following form:
Position Shares
Mr. Mukesh Kumar Vishani MD/ CEO
Mr. Naren Vishani Director
Mr. Harvinder
Singh Alag Director
Mrs. Satnam Singh
Alag Director
Mr. Premnath
Karkera Director
Zenufa Group of Companies Holding Company 100%
RELATED COMPANIES
Zenufa Group of Companies Parent company.
None Subsidiary company.
ZENUFA LABORATORIES SPRL Affiliated company.
None Shareholder of subject firm.
None Branches of the firm
OPERATIONS
Registered to operate wholesaling and retailing of pharmaceutical
products
Imports:
Exports: None
Trademarks: None
Terms of sale: Cash
(40%) and 30 days (60%), invoices.
Main Customers: firms
and organizations
Employees: 65
employees.
Vehicles: Several
motor vehicles.
Territory of
sales:
Location: Rented
premises, 5.000 square feet,
AUDITORS AND INSURANCE
Auditors: Information not available.
Insurance Brokers: Tausi
Assurance
FINANCE
Currency Reported:
Approx. Ex. Rate: 1 US Dollar = 1300
Fiscal Year End: December
31, 2010
Inflation: According
to information given by independent sources, the inflation at December
31st, 2010 was of 14%.
Financial Information Submitted
Profit and Loss (expressed in TZS.)
2010
Sales 5,800,000,000
BANK
Bank Name: CRDB Bank
Branch:
Comments: None
TRADE
REFERENCES
Experiences: Good
NOTARIAL
BONDS
None
COMMENTS / ADDITIONAL INFORMATION
This information was obtained from outside sources other than the
subject company itself and confirmed the above subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.45.11 |
|
|
1 |
Rs.72.91 |
|
Euro |
1 |
Rs.62.56 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.